中医药对冠心病患者血运重建术后治疗效果的补充数据表：中国北方前瞻性队列研究

数据集获取（Figshare）

• 源站标题：Data_Sheet_1_Therapeutic Effects of Traditional Chinese Medicine for Patients With Coronary Heart Disease After Treatment of Revascularization: A Prospective Cohort Study in the Northern of China.PDF
• DOI：10.3389/fcvm.2021.743262.s001
• 发布日期：2021-11-17
• 文件数：1 个
• 文件总体积：168.81 KB
• 源站页面：https://frontiersin.figshare.com/articles/dataset/Data_Sheet_1_Therapeutic_Effects_of_Traditional_Chinese_Medicine_for_Patients_With_Coronary_Heart_Disease_After_Treatment_of_Revascularization_A_Prospective_Cohort_Study_in_the_Northern_of_China_PDF/17030393

命令行下载

curl -L -o "Data_Sheet_1_Therapeutic Effects of Traditional Chinese Medicine for Patients With Coronary Heart Disease After Treatment of Revascularization: A Pros.PDF" "https://ndownloader.figshare.com/files/31498064"

文件清单

• Data_Sheet_1_Therapeutic Effects of Traditional Chinese Medicine for Patients With Coronary Heart Disease After Treatment of Revascularization: A Pros.PDF（168.81 KB）

文件总体积 168.81 KB（源站 API 实测）。

数据加载示例（图像类）

from PIL import Image
import glob, os

files = (glob.glob(os.path.join(path, "**", "*.png"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.jpg"), recursive=True)
       + glob.glob(os.path.join(path, "**", "*.tif"), recursive=True))
print("图像文件数:", len(files))
img = Image.open(files[0]); print("尺寸/模式:", img.size, img.mode)

# torchvision Dataset 方式:
# from torchvision import datasets
# ds = datasets.ImageFolder(path)  # 要求 子目录=类别

目录组织与标注格式以源站说明和下载后实际文件为准。

数据说明

Aim: To investigate the compliance and the outcome of Traditional Chinese Medicine (TCM) in patients with coronary heart disease (CHD) after treatment of revascularization.
Methods: In this prospective cohort study, the non-exposure group (NEG), low-exposure group (LEG), and high-exposure group (HEG) were divided after 2 years follow-up. The primary outcome was a composite of death from cardiovascular causes, non-lethal myocardial infarction, heart transplantation, or stroke. Time-to-event data were evaluated by using the Cox regression analysis with hazard ratios (HRs) and 95% CIs. Then, the two-sided p-values were calculated by using the Cox models. In order to indicate the therapeutic effects of TCM on the CHD after revascularization, the survival analysis and the nested case–control study were conducted separately.
Results: There were 1,003 patients with CHD enrolled, 356 patients (35.49%) did not choose the TCM, 379 patients (37.79%) used the TCM seldom, and only 268 patients (26.72%) used TCM regularly. A total of 653 patients with revascularization participated in the prospective cohort study. Over the duration of the trial, the primary endpoints occurred in 12 (4.35%), 11 (4.80%), and 2 (1.35%) patients in the NEG, LEG, and HEG, while the secondary endpoints occurred in 84 (30.43%), 57 (24.89%), and 15 (10.14%) patients in the NEG, LEG, and HEG, respectively. The occurrence time of secondary endpoint events in HEG was significantly postponed (p 0.05), but the percentage of HEG in the cases was extremely lower than the controls.
Conclusion: The HEG-TCM may improve the outcomes of the patients with CHD after treatment of revascularization.
Registration:http://www.chictr.org.cn. Unique identifier: ChiCTR-OOC-17012995.

许可

CC BY 4.0

引用

学术使用请引用 DOI 10.3389/fcvm.2021.743262.s001（source: https://frontiersin.figshare.com/articles/dataset/Data_Sheet_1_Therapeutic_Effects_of_Traditional_Chinese_Medicine_for_Patients_With_Coronary_Heart_Disease_After_Treatment_of_Revascularization_A_Prospective_Cohort_Study_in_the_Northern_of_China_PDF/17030393）。